Bax deficiency mediated drug resistance can be reversed by endoplasmic reticulum stress induced death signaling

Biochemical Pharmacology

Volumn 79, Issue 11, 2010, Pages 1589-1599

  Chandrika, Bhavya Balan ^a   Maney, Sathish Kumar ^a   Lekshmi, Swathi U ^a   Joseph, Jeena ^a   Seervi, Mahendra ^a   Praveen, K S ^a   Santhoshkumar, T R ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

Apoptosis; Autophagy; Bax mutation; Drug resistance; ER stress

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CAMPTOTHECIN; CYTOCHROME C; GLUCOSE REGULATED PROTEIN 78; KAEMPFEROL; PROTEIN BAX; THAPSIGARGIN; TUNICAMYCIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER RESISTANCE; CELL DEATH; CELL PROTECTION; COLON CANCER; CONTROLLED STUDY; DRUG TARGETING; ENDOPLASMIC RETICULUM STRESS; ENZYME RELEASE; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM; HUMANS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 77950066837     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.01.032     Document Type: Article

References (40)

1. Tredan O., Galmarini C.M., Patel K., Tannock I.F. Drug resistance and the solid tumor microenvironment 135. J Natl Cancer Inst 2007, 99:1441-1454.
2. Vaupel P., Thews O., Hoeckel M. Treatment resistance of solid tumors. Med Oncol 2001, 18:243-259.
3. LeBlanc H., Lawrence D., Varfolomeev E., Totpal K., Morlan J., Schow P., et al. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 2002, 8:274-281.
4. Jansson A., Sun X.-F. Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer. J Clin Oncol 2002, 20:811-816.
5. Duckworth C.A., Pritchard D.M. Suppression of apoptosis, crypt hyperplasia, and altered differentiation in the colonic epithelia of bak-null mice. Gastroenterology 2009, 136:943-952.
6. Burlacu A. Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 2003, 7:249-257.
7. Carthy C.M., Yanagawa B., Luo H., Granville D.J., Yang D., Cheung P., et al. Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection. Virology 2003, 313:147-157.
8. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 1998, 95:4997-5002.
9. Zhang L., Yu J., Park B.H., Kinzler K.W., Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 2000, 290:989-992.
10. Wei M.C., Zong W.-X., Cheng E.H.-Y., Lindsten T., Panoutsakopoulou V., Ross A.J., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730.
11. Gupta S. Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci 2001, 69:2957-2964.
12. Yagi O.K., Akiyama Y., Nomizu T., Iwama T., Endo M., Yuasa Y. Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas. Gastroenterology 1998, 114:268-274.
13. Degenhardt K., Chen G., Lindsten T., White E. BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell 2002, 2:193-203.
14. Ionov Y., Yamamoto H., Krajewski S., Reed J.C., Perucho M. Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci USA 2000, 97:10872-10877.
15. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J.C., et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997, 275:967-969.
16. Lynch H.T., de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003, 348:919-932.
17. Perucho M. Cancer of the microsatellite mutator phenotype. Biol Chem 1996, 377:675-684.
18. Tait S.W., Bouchier-Hayes L., Oberst A., Connell S., Green D.R. Live to dead cell imaging. Methods Mol Biol 2009, 559:33-48.
19. Goldstein J.C., Waterhouse N.J., Juin P., Evan G.I., Green D.R. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2000, 2:156-162.
20. Goldstein J.C., Munoz-Pinedo C., Ricci J.E., Adams S.R., Kelekar A., Schuler M., et al. Cytochrome c is released in a single step during apoptosis. Cell Death Differ 2005, 12:453-462.
21. Kawai H., Suzuki T., Kobayashi T., Ishii-Watabe A., Sakurai H., Ohata H., et al. Caspase cascade proceeds rapidly after cytochrome c release from mitochondria in tumor necrosis factor-alpha-induced cell death. J Pharmacol Sci 2007, 103:159-167.
22. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000, 19:5720-5728.
23. Spierings D., McStay G., Saleh M., Bender C., Chipuk J., Maurer U., et al. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 2005, 310:66-67.
24. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001, 15:2922-2933.
25. Vaupel P., Kelleher D.K., Höckel M. Oxygenation status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001, 28:29-35.
26. Brown J.M., Giaccia A.J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998, 58:1408-1416.
27. Panaretakis T., Pokrovskaja K., Shoshan M.C., Grander D. Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. J Biol Chem 2002, 277:44317-44326.
28. Von Haefen C., Wieder T., Gillissen B., Starck L., Graupner V., Dorken B., et al. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 2002, 21:4009-4019.
29. Meijerink J.P.P., Mensink E.J.B.M., Wang K., Sedlak T.W., Sloetjes A.W., de Witte T., et al. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood 1998, 91:2991-2997.
30. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature 1998, 396:643-649.
31. Hogarth L.A., Hall A.G. Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Blood 1999, 93:2671-2678.
32. Méndez O., Máñas S., Peinado M., Fabra A., Escobedo A., Moreno A., et al. Microsatellite instability is associated with the loss of apoptosis in ductal breast carcinomas. Breast Cancer Res Treat 2001, 65:171-177.
33. Cartron P.-F., Juin P., Oliver L., Martin S., Meflah K., Vallette F.M. Nonredundant role of Bax and Bak in bid-mediated apoptosis. Mol Cell Biol 2003, 23:4701-4712.
34. Munoz-Pinedo C., Guio-Carrion A., Goldstein J.C., Fitzgerald P., Newmeyer D.D., Green D.R. Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc Natl Acad Sci USA 2006, 103:11573-11578.
35. Mirjolet J.-F., Barberi-Heyob M., Didelot C., Peyrat J.-P., Abecassis J., Millon R., et al. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Br J Cancer 2000, 83:1380-1386.
36. Srinivasan S., Ohsugi M., Liu Z., Fatrai S., Bernal-Mizrachi E., Permutt M.A. Endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol 3-kinase/akt and increased glycogen synthase kinase-3{beta} in mouse insulinoma cells 54.4.968. Diabetes 2005, 54:968-975.
37. Rossier M.F., Python C.P., Burnay M.M., Schlegel W., Vallotton M.B., Capponi A.M. Thapsigargin inhibits voltage-activated calcium channels in adrenal glomerulosa cells. Biochem J 1993, 296(Pt 2):309-312.
38. Zong W.-X., Li C., Hatzivassiliou G., Lindsten T., Yu Q.-C., Yuan J., et al. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 2003, 162:59-69.
39. Nechushtan A., Smith C.L., Lamensdorf I., Yoon S.-H., Youle R.J. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J Cell Biol 2001, 153:1265-1276.
40. Sakamoto I., Yamada T., Ohwada S., Koyama T., Nakano T., Okabe T., et al. Mutational analysis of the BAK gene in 192 advanced gastric and colorectal cancers. Int J Mol Med 2004, 13:53-55.